Staar Surgical price target lowered to $44 from $50 at Stifel

Stifel lowered the firm’s price target on Staar Surgical to $44 from $50 and keeps a Buy rating on the shares. Shares have faced pressure recently due to concerns that 2025/2026 numbers could soon reset, says the firm, which believes it is increasingly likely this occurs, but feel shares have already largely factored it in. Given this view, Stifel would view a guidance cut as “more of a clearing event” and would be buyers of recent weakness with a longer-term bias, the analyst tells investors.